| Typicality: | 0.478 |
| Saliency: | 0.527 |
| currently | 28 | temporal |
| for other cancers | 7 | other |
| in dogs with osteosarcoma | 6 | other |
| drug → be in → clinical trials | 121 |
| drug → be in → clinical trial | 14 |
| drug → be under → clinical trials | 9 |
| drug → be in → human trials | 4 |
| drug → be in → clinical trial stage | 3 |
| drug → be available in → clinical trials | 3 |
| drug → be in → advanced clinical trials | 3 |
| negative | neutral | positive |
| 0.101 | 0.619 | 0.280 |
| Raw frequency | 157 |
| Normalized frequency | 0.527 |
| Modifier score | 0.509 |
| Perplexity | 36.827 |